
Wuhan Wan Song Tang Health Industry Co., Ltd. is a subsidiary of the Wan Song Tang Group, strategically located in the Dongxihu Development Zone of Wuhan, Hubei Province. The company specializes in the cultivation, R&D, production, and global distribution of health-oriented tea products, dietary fiber supplements, and traditional Chinese herbal formulations. With a vertically integrated business model spanning tea plantations, OEM services, e-commerce, and cross-border trade, it aims to establish itself as a globally recognized brand in the health and wellness industry.
Leveraging partnerships with over ten renowned medical institutions worldwide, the company combines cutting-edge technology with traditional Chinese medicine principles. Its state-of-the-art production facilities include advanced tea bagging and dietary powder lines, GMP-certified packaging workshops, and rigorous quality control systems compliant with ISO 9001, QS, and GMP standards.
As a pioneer in “tea therapy,” the company holds seven patented technologies and offers over 20 health products approved by national regulatory authorities. Its flagship products—such as Maca Tea, Qingqian Willow Tea, and “Big Belly” Tea—target weight management, detoxification, blood sugar regulation, and immune enhancement, rooted in centuries-old herbal wisdom.
With a robust omni-channel strategy encompassing traditional and online sales, Wuhan Wan Song Tang has built a reputation for innovation and reliability. Committed to promoting holistic wellness, it continues to expand its global footprint while adhering to its mission of revitalizing traditional health practices through modern science.